We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00185913
First Posted: September 16, 2005
Last Update Posted: April 22, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Stanford University
  Purpose
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Resource links provided by NLM:


Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA
blood

Estimated Enrollment: 50
Study Start Date: September 2000
Study Completion Date: May 2008
Primary Completion Date: October 2003 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors
Criteria

Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors

Exclusion Criteria:- Patients without non-small cell lung cancer

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00185913


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Quynh-Thu Le Stanford University
  More Information

Responsible Party: Quynh-Thu Le, Stanford University School of Medicine
ClinicalTrials.gov Identifier: NCT00185913     History of Changes
Other Study ID Numbers: LUN0006
75318
First Submitted: September 12, 2005
First Posted: September 16, 2005
Last Update Posted: April 22, 2010
Last Verified: April 2010

Additional relevant MeSH terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms


To Top